Loading…
FARECon featuring Teen Summit 2018 has ended
Please note that the conference agenda is subject to change.
Back To Schedule
Sunday, November 4 • 8:30am - 9:20am
Participating in a Clinical Trial: Emerging Therapies from Stanford University

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Currently there are no FDA approved treatment options for food allergies and the standard of care remains avoidance and treatment of symptoms due to accidental ingestion. During this session, clinical trials involving therapeutic options in food allergy will be discussed including oral immunotherapy, sublingual immunotherapy, epicutaneous immunotherapy, peanut vaccine as well as adjunctive therapies such as omalizumab, anti-IL33, and dupilumab. In addition to therapies, an overview of participation in a clinical trial will also be reviewed along with the benefits as well as challenges.

This session is approved for one hour of continuing education credits from the Academy of Nutrition & Dietetics.
Speakers
avatar for Sayantani Sindher, MD

Sayantani Sindher, MD

Dr. Sindher joined the Sean N. Parker Center for Allergy & Asthma Research at Stanford University in January 2017. She is a Clinical Assistant Professor of Allergy and Immunology in the Department of Medicine, division of Pulmonary & Critical Care Medicine. She divides her time between... Read More →

Sunday November 4, 2018 8:30am - 9:20am PST
Studio B
  Registered Dietitian & Adult

Attendees (19)